Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000947871-17-001023
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-20 17:12:52
Reporting Period:
2017-12-18
Accepted Time:
2017-12-20 17:12:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583648 Pieris Pharmaceuticals Inc. PIRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055949 D Samuel Isaly 601 Lexington Avenue, 54Th Floor
New York NY 10022
No No Yes No
1055951 Orbimed Advisors Llc 601 Lexington Avenue, 54Th Floor
New York NY 10022
No No Yes No
1432241 Orbimed Capital Gp Iii Llc 601 Lexington Avenue, 54Th Floor
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-18 27,241 $2.00 7,221,463 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 259 $2.00 65,657 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 5,227 $3.00 7,226,690 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 50 $3.00 65,707 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 6,654 $2.62 7,233,344 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 63 $2.62 65,770 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 8,717 $1.94 7,242,061 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 83 $1.94 65,853 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 10,180 $1.62 7,252,241 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 97 $1.62 65,950 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 19,811 $1.59 7,272,052 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 189 $1.59 66,139 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 8,097 $2.05 7,280,149 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 77 $2.05 66,216 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 9,642 $1.73 7,289,791 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 92 $1.73 66,308 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 10,182 $1.64 7,299,973 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 97 $1.64 66,405 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 14,858 $2.01 7,314,831 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 142 $2.01 66,547 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 10,216 $2.01 7,325,047 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 97 $2.01 66,644 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 10,447 $2.32 7,335,494 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 99 $2.32 66,743 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 4,971 $5.64 7,340,465 No 4 M Indirect See Footnotes
Common Stock Acquisiton 2017-12-18 47 $5.64 66,790 No 4 M Indirect See Footnotes
Common Stock Disposition 2017-12-18 146,243 $5.70 7,194,222 No 4 S Indirect See Footnotes
Common Stock Disposition 2017-12-18 1,392 $5.70 65,398 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 M Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-12-18 27,241 $0.00 27,241 $2.00
Common Stock Stock Option (right to buy) Disposition 2017-12-18 259 $0.00 259 $2.00
Common Stock Stock Option (right to buy) Disposition 2017-12-18 5,227 $0.00 5,227 $3.00
Common Stock Stock Option (right to buy) Disposition 2017-12-18 50 $0.00 50 $3.00
Common Stock Stock Option (right to buy) Disposition 2017-12-18 6,654 $0.00 6,654 $2.62
Common Stock Stock Option (right to buy) Disposition 2017-12-18 63 $0.00 63 $2.62
Common Stock Stock Option (right to buy) Disposition 2017-12-18 8,717 $0.00 8,717 $1.94
Common Stock Stock Option (right to buy) Disposition 2017-12-18 83 $0.00 83 $1.94
Common Stock Stock Option (right to buy) Disposition 2017-12-18 10,180 $0.00 10,180 $1.62
Common Stock Stock Option (right to buy) Disposition 2017-12-18 97 $0.00 97 $1.62
Common Stock Stock Option (right to buy) Disposition 2017-12-18 19,811 $0.00 19,811 $1.59
Common Stock Stock Option (right to buy) Disposition 2017-12-18 189 $0.00 189 $1.59
Common Stock Stock Option (right to buy) Disposition 2017-12-18 8,097 $0.00 8,097 $2.05
Common Stock Stock Option (right to buy) Disposition 2017-12-18 77 $0.00 77 $2.05
Common Stock Stock Option (right to buy) Disposition 2017-12-18 9,642 $0.00 9,642 $1.73
Common Stock Stock Option (right to buy) Disposition 2017-12-18 92 $0.00 92 $1.73
Common Stock Stock Option (right to buy) Disposition 2017-12-18 10,182 $0.00 10,182 $1.64
Common Stock Stock Option (right to buy) Disposition 2017-12-18 97 $0.00 97 $1.64
Common Stock Stock Option (right to buy) Disposition 2017-12-18 14,858 $0.00 14,858 $2.01
Common Stock Stock Option (right to buy) Disposition 2017-12-18 142 $0.00 142 $2.01
Common Stock Stock Option (right to buy) Disposition 2017-12-18 10,216 $0.00 10,216 $2.01
Common Stock Stock Option (right to buy) Disposition 2017-12-18 97 $0.00 97 $2.01
Common Stock Stock Option (right to buy) Disposition 2017-12-18 10,447 $0.00 10,447 $2.32
Common Stock Stock Option (right to buy) Disposition 2017-12-18 99 $0.00 99 $2.32
Common Stock Stock Option (right to buy) Disposition 2017-12-18 4,971 $0.00 4,971 $5.64
Common Stock Stock Option (right to buy) Disposition 2017-12-18 47 $0.00 47 $5.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
0 2018-02-15 No 4 M Indirect
Footnotes
  1. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on December 17, 2014 for services as a director of the Issuer. The award included stock options relating to a total of 30,000 shares of the Issuer's Common Stock and was scheduled to vest quarterly over three years beginning March 31, 2015, with 100% of the total shares vested and exercisable on March 31, 2018, subject to the director's provision of service to the issuer on each vesting date. Mr. Khuong is no longer a director of the Issuer.
  2. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on April 30, 2015 for services as a director of the Issuer. The award included stock options relating to a total of 5,277 shares of the Issuer's Common Stock and was vested and exercisable on April 30, 2015. Mr. Khuong is no longer a director of the Issuer.
  3. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on July 15, 2015 for services as a director of the Issuer. The award included stock options relating to a total of 6,717 shares of the Issuer's Common Stock and was vested and exercisable on July 15, 2015. Mr. Khuong is no longer a director of the Issuer.
  4. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on October 15, 2015 for services as a director of the Issuer. The award included stock options relating to a total of 8,800 shares of the Issuer's Common Stock and was vested and exercisable on October 15, 2015. Mr. Khuong is no longer a director of the Issuer.
  5. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on January 15, 2016 for services as a director of the Issuer. The award included stock options relating to a total of 10,277 shares of the Issuer's Common Stock and was vested and exercisable on January 15, 2016. Mr. Khuong is no longer a director of the Issuer.
  6. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on February 16, 2016 for services as a director of the Issuer. The award included stock options relating to a total of 20,000 shares of the Issuer's Common Stock and was scheduled to vest in four equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016 with 100% of the total shares vested and exercisable on December 31, 2016, subject to the director's provision of service to the issuer on each vesting date. Mr. Khuong is no longer a director of the Issuer.
  7. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on April 27, 2016 for services as a director of the Issuer. The award included stock options relating to a total of 8,174 shares of the Issuer's Common Stock and was vested and exercisable on April 27, 2016. Mr. Khuong is no longer a director of the Issuer.
  8. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on July 25, 2016 for services as a director of the Issuer. The award included stock options relating to a total of 9,734 shares of the Issuer's Common Stock and was vested and exercisable on July 25, 2016. Mr. Khuong is no longer a director of the Issuer.
  9. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on October 25, 2016 for services as a director of the Issuer. The award included stock options relating to a total of 10,279 shares of the Issuer's Common Stock and was vested and exercisable on October 25, 2016. Mr. Khuong is no longer a director of the Issuer.
  10. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on January 25, 2017 for services as a director of the Issuer. The award included stock options relating to a total of 20,000 shares of the Issuer's Common Stock and was scheduled to vest in four equal installments on each of March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017 with 100% of the total shares vested and exercisable on December 31, 2017, subject to the director's provision of service to the issuer on each vesting date. Mr. Khuong is no longer a director of the Issuer.
  11. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on January 25, 2017 for services as a director of the Issuer. The award included stock options relating to a total of 10,313 shares of the Issuer's Common Stock and was vested and exercisable on January 25, 2017. Mr. Khuong is no longer a director of the Issuer.
  12. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on April 25, 2017 for services as a director of the Issuer. The award included stock options relating to a total of 10,546 shares of the Issuer's Common Stock and was vested and exercisable on April 25, 2017. Mr. Khuong is no longer a director of the Issuer.
  13. The stock options were included in an award to Chau Khuong, an employee of the Reporting Persons, made on July 25, 2017 for services as a director of the Issuer. The award included stock options relating to a total of 5,018 shares of the Issuer's Common Stock and was vested and exercisable on July 25, 2017. Mr. Khuong is no longer a director of the Issuer.
  14. These Shares are held of record by OrbiMed Private Investments III, LP ("OPI III"). OrbiMed Capital GP III LLC ("GP III") is the general partner of OPI III, and OrbiMed Advisors LLC ("Advisors") is the managing member of GP III. Samuel D. Isaly ("Isaly"), a natural person, is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, GP III, Advisors and Isaly may be deemed to have voting and investment power over the securities held by OPI III and as a result may be deemed to have beneficial ownership over such securities.
  15. These Shares are held of record by OrbiMed Associates III, LP ("Associates III"). Advisors is the general partner of Associates III. Isaly is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, Advisors and Isaly may be deemed to have voting and investment power over the securities held by Associates III and as a result may be deemed to have beneficial ownership over such securities.
  16. This report on Form 4 is jointly filed by GP III, Advisors, and Isaly. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.